Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Artur, Zimmermann"'
Autor:
Sandra Bufe, Artur Zimmermann, Sarina Ravens, Immo Prinz, Laura Elisa Buitrago-Molina, Robert Geffers, Norman Woller, Florian Kühnel, Steven R. Talbot, Fatih Noyan, Michael Peter Manns, Heiner Wedemeyer, Matthias Hardtke-Wolenski, Elmar Jaeckel, Ana C. Davalos-Misslitz
Publikováno v:
Liver Cancer (2022)
Background: Checkpoint inhibitors act on exhausted CD8+ T cells and restore their effector function in chronic infections and cancer. The underlying mechanisms of action appear to differ between different types of cancer and are not yet fully underst
Externí odkaz:
https://doaj.org/article/965c2a4212154815948f7cc4a347137a
Autor:
Bettina Hartmann, Stefanie Lanzinger, Peter Bramlage, Felix Groß, Thomas Danne, Siegfried Wagner, Dietmar Krakow, Artur Zimmermann, Christian Malcharzik, Reinhard W Holl
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183235 (2017)
To assess differences in demographics, treatment and outcome of lean (LD) compared to overweight and obese people with diabetes clinically classified as type 2 diabetes mellitus (T2DM).We combined data from the German DIVE (Diabetes Versorgungs-Evalu
Externí odkaz:
https://doaj.org/article/e41bbe509c8f496a9eafccf06db18d8c
Autor:
Reinhard Welp, Siegfried Wagner, Reinhard W. Holl, Peter Fasching, Sebastian M. Schmid, Stefanie Lanzinger, Artur Zimmermann
Publikováno v:
Diabetes Research and Clinical Practice. 146:162-171
Objectives Failure to intensify treatment of patients with type 2 diabetes (T2D) in a timely manner is a common challenge. If newer oral anti-diabetic drugs (NOADs) such as dipeptidyl peptidase-4 inhibitors (DPP-4i) and sodium/glucose cotransporter 2
Autor:
Michael Hummel, Artur Zimmermann, Reinhard W. Holl, Barbara Bohn, Hans Martin Reuter, Jörg Gloyer, Thomas Danne, Reinhard Welp, Stefan Sziegoleit, Peter Bramlage, Christian Wagner, Matthias Kaltheuner
Publikováno v:
Wiener Medizinische Wochenschrift. 168:415-422
Glargin U300 (Gla-300) ist eine Weiterentwicklung von Glargin U100 (Gla-100) und seit 2015 in Deutschland und Osterreich erhaltlich. Ziel war es zu untersuchen, wie sich auf Gla-300 ein-/umgestellte Patienten von zeitgleich auf Gla-100 eingestellte P
Autor:
Dpv Initiative, D Stoyanova, HJ Ziegelasch, Artur Zimmermann, Anke Schwandt, Bernd Stratmann, S Mühldorfer, Heise N, Tschoepe D, Reinhard W. Holl
Publikováno v:
Diabetic Medicine
Aim Comparing people with Type 2 diabetes mellitus with and without heart failure in terms of metabolic control, therapeutic regimen and comorbidities. Methods The Prospective Diabetes Registry (DPV) is a longitudinal documentation system for demogra
Autor:
Dietmar Krakow, Siegfried Wagner, Reinhard W. Holl, Felix Groß, Thomas Danne, Artur Zimmermann, Bettina Hartmann, Peter Bramlage, Stefanie Lanzinger, Christian Malcharzik
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 8, p e0183235 (2017)
PLoS ONE, Vol 12, Iss 8, p e0183235 (2017)
Aims To assess differences in demographics, treatment and outcome of lean (LD) compared to overweight and obese people with diabetes clinically classified as type 2 diabetes mellitus (T2DM). Materials and methods We combined data from the German DIVE
Autor:
Barbara, Bohn, Peter, Bramlage, Christian, Wagner, Matthias, Kaltheuner, Reinhard, Welp, Stefan, Sziegoleit, Artur, Zimmermann, Hans Martin, Reuter, Michael, Hummel, Jörg, Gloyer, Reinhard W, Holl, Thomas, Danne
Publikováno v:
Wiener medizinische Wochenschrift (1946). 168(15-16)
Glargine U300 (Gla-300) is a further development of glargine U100 (Gla-100). Since 2015, Gla-300 has been available in Germany and Austria. We compared patients initiating therapy with Gla-300 with patients starting with Gla-100. Moreover, it was inv
Autor:
Katja Gollisch, Artur Zimmermann, Volker Zindel, Barbara Bohn, Sigrun Merger, Dpv Initiative, Christian Wagner, Desiree Dunstheimer, Florian Kopp, Reinhard W. Holl
Publikováno v:
Diabetes research and clinical practice. 129
Background The long-acting insulin analogue degludec is a therapeutic option for patients with type 1 (T1D) or type 2 diabetes (T2D). Aim of this analysis was to investigate differences in clinical characteristics of patients before and after initiat
Autor:
M Schütt, A Tytko, Reinhard W. Holl, E Siegel, Artur Zimmermann, Michael Hummel, Dpv Initiative, Jochen Seufert, R Hood
Publikováno v:
Experimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 123(10)
Effects of diabetes treatment are strongly connected to individual factors, but the relevant role of gender has not been addressed so far. This observational study evaluates whether monotherapy with lifestyle, metformin or sulfonylurea has gender-spe
Autor:
Artur, Zimmermann
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 8(3)
The present overview summarizes important knowledge having accumulated during the last years. The liver maintains a steady mass which is basically controlled by a delicate balance between cell gain and cell loss. However, reconstitution of the organ